Advocacy Archive
Learn about past public policy initiatives where FORCE ensured that the hereditary cancer community was represented by signing up for our community newsletter.
- Support Broader Access to Genetic Counseling
- Florida Enacts Sweeping Genetic Protection Law
- Medicare Finalizes Genetic Testing Policy
- Fraud Alert! Genetic Test Scams are a Growing Problem
- New Legislative Effort Could Wipe Out Laws Preventing Gene Patents
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- FORCE Leads the Charge for Medicaid Coverage of Genetic Testing
- FDA Approves New Direct-to-Consumer Genetic Test for 3 BRCA Mutations
- Clarification Includes Survivors in BRCA Screening Guidelines
- Supreme Court Rules Gene Patents Unlawful
- FORCE Statement on Supreme Court's Roe v. Wade Decision
- Protections Against Genetic Discrimination vs. Pre-existing Conditions
- Florida Enacts Sweeping Genetic Protection Law
- Fraud Alert! Genetic Test Scams are a Growing Problem
- Lawsuit Targets Wellness Program Penalties and Invasion of Privacy
- Lawsuit Challenges ACA Preexisting Conditions Protections
- Statement Sets the Record Straight on AHCA and HR 1313
- Genetic Information Nondiscrimination Act (GINA)
- Support Broader Access to Genetic Counseling
- FORCE Fights for Our Community, COVID Relief
- Florida Enacts Sweeping Genetic Protection Law
- Fraud Alert! Genetic Test Scams are a Growing Problem
- Statement Sets the Record Straight on AHCA and HR 1313
- EARLY Act Brings Young Breast Cancer to Forefront
- Establishment of National HBOC Week and Previvor Day
- Bill Aims to Address Ongoing Survivorship Care Needs
- FORCE Statement on Supreme Court's Roe v. Wade Decision
- Support Broader Access to Genetic Counseling
- Protect Access to Free Annual Screening Mammograms for Women Ages 40-49
- Protections Against Genetic Discrimination vs. Pre-existing Conditions
- FORCE Fights for Our Community, COVID Relief
- Medicare Finalizes Genetic Testing Policy
- Mammograms for Women Age 40-49 Preserved Until 2020
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- FORCE Supports Chemotherapy Parity Initiatives
- ACA Unconstitutional? What Does This Mean for Preventive Care and Pre-Existing Conditions?
- New Federal Regulations and Proposals May Hurt High-Risk Cancer Community
- Lawsuit Challenges ACA Preexisting Conditions Protections
- FORCE Leads the Charge for Medicaid Coverage of Genetic Testing
- Ovarian Cancer Screening for High-Risk Women
- Prostate Cancer Screening Guidelines Fall Short
- Clarification Includes Survivors in BRCA Screening Guidelines
- Statement Sets the Record Straight on AHCA and HR 1313
- Protect Access to Free Annual Screening Mammograms for Women Ages 40-49
- FORCE Fights for Our Community, COVID Relief
- FORCE Weighs in on Breast Implant Safety and Informed Consent
- Mammograms for Women Age 40-49 Preserved Until 2020
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- ACA Unconstitutional? What Does This Mean for Preventive Care and Pre-Existing Conditions?
- Cancer Research Funding Preserved
- Ovarian Cancer Screening for High-Risk Women
- Prostate Cancer Screening Guidelines Fall Short
- FDA Issues New Communication RE: Breast Implants and Reports of Cancer
- FDA Issues New Breast Implant Labeling Recommendations to Improve Patient Communication
- Support Equitable Coverage of Oral Chemotherapy
- FDA Updates Breast Implant Safety Info, Releases Educational Video
- Medicare Finalizes Genetic Testing Policy
- FORCE Weighs in on Breast Implant Safety and Informed Consent
- FORCE Supports Chemotherapy Parity Initiatives
- New Federal Regulations and Proposals May Hurt High-Risk Cancer Community
- Federal "Right to Try" Legislation Passes, Signed by President
- Cancer Research Funding Preserved
Take Action Now
Become an Advocate
2024 Priorities
Federal Policy
State Policy
News Briefs
7/16/2024 - Supported a statement expressing concern about the Supreme Court’s decision to eliminate the Chevron doctrine deference precedent and the impact the decision may have on those affected by colorectal and other cancers.
7/2/2024 - Joined more than 50 organizations in submitting feedback on the draft guidance for the second cycle of the Medicare Drug Price Negotiation Program, which will impact drug pricing as well as innovation.
5/14/2024 - Urged the House and Senate Appropriations Committees to create a Colorectal Cancer Research Program within the Department of Defense Congressionally Directed Medical Research Programs.
Sponsored By:
